Non-nucleoside reverse transcriptase inhibitors

   
   

Disclosed herein are compounds of formula Ar.sup.1--X--W--Ar.sup.2 wherein Ar.sup.1 and Ar.sup.2 represent aryl groups characterized generally as aromatic heterocycles (e.g. imidazolyl or tetrazolyl) or carbocycles (e.g. phenyl or naphthalenyl); the aryl groups are optionally substituted or fused with other heterocycles or carbocycles; the aryl groups can bear substituents such as alkyl, halo or O-alkyl. X is a heteroatom, a valence bond or an optionally substituted divalent methylene, and W represents a spacer; typical spacers include divalent alkylene or alkylene-amido, -amido or -oxy radicals, which may optionally be substituted (e.g. hydroxyl or oxo). A typical compound is a derivative of 2-(N-napthalenyltetrazolylthio)-N-(2-nitrophenyl)acetamide. The compounds have inhibitory activity against Wild Type and single or double mutant strains of HIV.

 
Web www.patentalert.com

< Agonists and antagonists of moxifin for the treatment of metabolic disorders

< Cyclohepta[b][1,4]diazepino[6,7,1,-hi]indoles and derivatives

> Propanolaminomethyltetralines, their preparation and pharmaceutical composition comprising same

> Methods of treating metabolic syndrome using dopamine receptor agonists

~ 00167